How many insider trades does FilingIQ track for ANIX?

FilingIQ tracks 118 Form 4 insider transactions for ANIX (Anixa Biosciences Inc), covering filings from Oct 25, 2018 onwards. 2 of those were filed in the last 90 days.

Are ANIX insiders net buyers or net sellers?

Across the full Form 4 history for ANIX, 83 transactions (70%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ANIX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is ANIX in?

Anixa Biosciences Inc (ANIX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $88.18M.

ANIX insider trading

NasdaqCM Healthcare

Anixa Biosciences Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

118

Last 90 days

Buys / sells

70% / 1%

Market cap

$88.18M

About Anixa Biosciences Inc

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Company website: www.anixa.com

ANIX insider activity at a glance

FilingIQ has scored 118 insider transactions for ANIX since Oct 25, 2018. The most recent filing in our index is dated Jun 16, 2026.

Across the full history, 83 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ANIX insider trades is 54.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live ANIX trades on FilingIQ Raw filings on SEC EDGAR

Latest ANIX Form 4 filings

Catelani Michael President, COO, & CFO

P Jan 15, 2025

KUMAR AMIT Chief Executive Officer

P Jan 15, 2025

Catelani Michael President, COO, & CFO

P Jun 7, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,204

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 159

Guardant Health, Inc.

First Tracks Biotherapeutics, Inc.

KALV 133

KalVista Pharmaceuticals, Inc.

Frequently asked

How many insider trades does FilingIQ track for ANIX?: FilingIQ tracks 118 Form 4 insider transactions for ANIX (Anixa Biosciences Inc), covering filings from Oct 25, 2018 onwards. 2 of those were filed in the last 90 days.
Are ANIX insiders net buyers or net sellers?: Across the full Form 4 history for ANIX, 83 transactions (70%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ANIX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ANIX in?: Anixa Biosciences Inc (ANIX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $88.18M.

Methodology & sources

Every ANIX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.